Asymmetric organocatalysis: an enabling technology for medicinal chemistry

被引:313
作者
Han, Bo [1 ]
He, Xiang-Hong [1 ]
Liu, Yan-Qing [1 ]
He, Gu [3 ,4 ]
Peng, Cheng [1 ]
Li, Jun-Long [1 ,2 ]
机构
[1] Chengdu Univ Tradit Chinese Med, State Key Lab Southwestern Chinese Med Resources, Chengdu 611137, Peoples R China
[2] Chengdu Univ, Sch Pharm, Sichuan Ind Inst Antibiot, Antibiot Res & Reevaluat Key Lab Sichuan Prov, Chengdu 610106, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[4] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
TRIFLUOROMETHYL KETIMINES SYNTHESIS; DECARBOXYLATIVE MANNICH REACTION; CANCER-CELL-PROLIFERATION; SMALL-MOLECULE INHIBITORS; FRIEDEL-CRAFTS REACTION; HIGH-YIELDING SYNTHESIS; ACID HALF-THIOESTERS; KEY BUILDING-BLOCK; ONE-POT SYNTHESIS; ENANTIOSELECTIVE SYNTHESIS;
D O I
10.1039/d0cs00196a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The efficacy and synthetic versatility of asymmetric organocatalysis have contributed enormously to the field of organic synthesis since the early 2000s. As asymmetric organocatalytic methods mature, they have extended beyond the academia and undergone scale-up for the production of chiral drugs, natural products, and enantiomerically enriched bioactive molecules. This review provides a comprehensive overview of the applications of asymmetric organocatalysis in medicinal chemistry. A general picture of asymmetric organocatalytic strategies in medicinal chemistry is firstly presented, and the specific applications of these strategies in pharmaceutical synthesis are systematically described, with a focus on the preparation of antiviral, anticancer, neuroprotective, cardiovascular, antibacterial, and antiparasitic agents, as well as several miscellaneous bioactive agents. The review concludes with a discussion of the challenges, limitations and future prospects for organocatalytic asymmetric synthesis of medicinally valuable compounds.
引用
收藏
页码:1522 / 1586
页数:65
相关论文
共 391 条
[1]   The ever-expanding role of asymmetric covalent organocatalysis in scalable, natural product synthesis [J].
Abbasov, Mikail E. ;
Romo, Daniel .
NATURAL PRODUCT REPORTS, 2014, 31 (10) :1318-1327
[2]  
Adams HA, 1997, ANAESTHESIST, V46, P1026, DOI 10.1007/s001010050503
[3]   Reductive Amination in the Synthesis of Pharmaceuticals [J].
Afanasyev, Oleg, I ;
Kuchuk, Ekaterina ;
Usanov, Dmitry L. ;
Chusov, Denis .
CHEMICAL REVIEWS, 2019, 119 (23) :11857-11911
[4]   Combinations of Aminocatalysts and Metal Catalysts: A Powerful Cooperative Approach in Selective Organic Synthesis [J].
Afewerki, Samson ;
Cordova, Armando .
CHEMICAL REVIEWS, 2016, 116 (22) :13512-13570
[5]   Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes [J].
Ahrén, B ;
Landin-Olsson, M ;
Jansson, PA ;
Svensson, M ;
Holmes, D ;
Schweizer, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2078-2084
[6]   Applications of asymmetric organocatalysis in medicinal chemistry [J].
Aleman, Jose ;
Cabrera, Silvia .
CHEMICAL SOCIETY REVIEWS, 2013, 42 (02) :774-793
[7]   Marilines A-C: Novel Phthalimidines from the Sponge-Derived Fungus Stachylidium sp. [J].
Almeida, Celso ;
Hemberger, Yasmin ;
Schmitt, Sven Marcel ;
Bouhired, Sarah ;
Natesan, Lavanya ;
Kehraus, Stefan ;
Dimas, Konstantinos ;
Guetschow, Michael ;
Bringmann, Gerhard ;
Koenig, Gabriele M. .
CHEMISTRY-A EUROPEAN JOURNAL, 2012, 18 (28) :8827-8834
[8]   History of antimicrobial drug discovery: Major classes and health impact [J].
Aminov, Rustam .
BIOCHEMICAL PHARMACOLOGY, 2017, 133 :4-19
[9]   ANTIMALARIAL ACTIVITY OF SESQUITERPENES FROM THE MARINE SPONGE ACANTHELLA-KLETHRA [J].
ANGERHOFER, CK ;
PEZZUTO, JM ;
KONIG, GM ;
WRIGHT, AD ;
STICHER, O .
JOURNAL OF NATURAL PRODUCTS, 1992, 55 (12) :1787-1789
[10]  
[Anonymous], 2012, LANCET, DOI DOI 10.1016/S0140-6736(12)61728-0